Innovative Strategies for Early Diagnosis of Pancreatic Adenocarcinoma at the Core of the Early Career Researchers' Meeting within the COST TRANSPAN Action

A session dedicated to "Personalized Approaches to the Early Diagnosis of Pancreatic Adenocarcinoma" will be one of the highlights of the Early Career Investigator's Meeting, organized under the auspices of the COST Action 21116 – TRANSPAN. This scientific networking initiative brings together young researchers from across Europe who aim to accelerate progress in understanding and treating one of the most aggressive types of cancer.

During the session, PhD students and postdoctoral researchers will present their latest discoveries in key areas such as the identification of new biomarkers, the development of advanced imaging techniques, and the implementation of diagnostic tools based on artificial intelligence.

The event encourages interdisciplinary collaboration by bringing together expertise from molecular biology, bioinformatics, and clinical research. Topics covered will include advances in liquid biopsy, multi-omic profiling, and precision medicine solutions—all with the potential to radically transform the way early detection of pancreatic cancer is performed.

Interactive discussions will create a conducive environment for the exchange of ideas and provide participants with an integrated perspective on current challenges and emerging opportunities in this highly relevant field.

By supporting early-career researchers and fostering international collaborations, the meeting contributes to the development of a robust network of experts committed to improving personalized diagnosis and, consequently, survival rates for patients affected by pancreatic adenocarcinoma.

Program agenda!